TheProfitWatch

AIM - AIM ImmunoTech Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.73 -0.08 (-2.93%) --- --- --- -0.13 (-4.76%) 0.0 (0.0%) 0.0 (0.0%) 0.03 (1.17%)

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies. Its flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) molecule being developed for globally important cancers, viral diseases, and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS).

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.05
Diluted EPS:
-0.05
Basic P/E:
-53.0
Diluted P/E:
-53.0
RSI(14) 1m:
50.0
VWAP:
2.65
RVol:
0.7802

Events

Period Kind Movement Occurred At
1m Price decrease 1m 2.6 -0.05 (-1.89%) Oct 15 09:30
60m Price decrease 60m 2.58 -0.15 (-5.49%) Oct 15 04:26

Related News